WHO suspends HCQ clinical trial on COVID-19 patients
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A World Health Organization study examining hydroxychloroquine — the controversial anti-malarial drug - has stopped amid safety concerns of prescribing the drug as a treatment for the coronavirus.

• For now, a trial looking into the effectiveness of the drug in treating coronavirus has been suspended temporarily, WHO Director-General Tedros Adhanom Ghebreyesus said on 25 May, while adding the drug is still generally seen as safe in treating malaria.

• Ghebreyesus cited the paper published in the medical journal "The Lancet" as a reason for suspending the trial

• The paper links hydroxychloroquine to an increased risk of death and heart problems compared with those who are not taking the drug. (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext)

• The use of the drug to treat coronavirus first came to prominence in March, after a small trial from a French doctor showed that the drug may have had some positive effect in treating coronavirus.

• Before 25 May 2020, the drug was part of a “Solidarity Trial” of drugs the WHO was testing as potential treatments for coronavirus.

• Remdesivir, Lopinavir/Ritonavir and Lopinavir/Ritonavir with Interferon beta-1a — these are the drugs still being studied by the WHO as part of its “Solidarity” clinical trial.

Note: The Lancet study on "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19" cited by WHO is attached pdf.

Source: https://indianexpress.com/article/india/coronavirus-solidarity-trial-who-suspends-allocation-of-patients-to-hcq-arm-for-now-6427225/
Dr. T●●●●z H●●●●●●i and 7 others like this7 shares
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
It is interesting to note that our science is not an exact science. However the contradictions being raised are suspicious of political involvement. A drug which is still being given as a prophylaxis,is now no longer being even considered by WHO for trials. So,the question is,"Who" is right?
May 26, 2020Like4
Dr. N●●●●a G●●●a
Dr. N●●●●a G●●●a Obstetrics and Gynaecology
Time is the biggest decider as yhe time passes we get to know fee facts and become knowledgable. Penicillin is today in the world because first ten pts in trial had no anaphylaxis. So research and truals are part of knowing more for further evaaluation. Same way Rhesus factor came into knowledge.
May 26, 2020Like2